195 related articles for article (PubMed ID: 16503743)
1. Adult and paediatric poor metabolisers of desloratadine: an assessment of pharmacokinetics and safety.
Prenner B; Kim K; Gupta S; Khalilieh S; Kantesaria B; Manitpisitkul P; Lorber R; Wang Z; Lutsky B
Expert Opin Drug Saf; 2006 Mar; 5(2):211-23. PubMed ID: 16503743
[TBL] [Abstract][Full Text] [Related]
2. Safety of desloratadine syrup in children.
Bloom M; Staudinger H; Herron J
Curr Med Res Opin; 2004 Dec; 20(12):1959-65. PubMed ID: 15701213
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.
Bachert C; Maurer M
Clin Drug Investig; 2010; 30(2):109-22. PubMed ID: 20067329
[TBL] [Abstract][Full Text] [Related]
4. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
DuBuske L
Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
[TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of desloratadine for the management of allergic disease.
Berger WE
Drug Saf; 2005; 28(12):1101-18. PubMed ID: 16329713
[TBL] [Abstract][Full Text] [Related]
6. Desloratadine: a nonsedating antihistamine.
Limon L; Kockler DR
Ann Pharmacother; 2003 Feb; 37(2):237-46; quiz 313-6. PubMed ID: 12549956
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
Devillier P; Roche N; Faisy C
Clin Pharmacokinet; 2008; 47(4):217-30. PubMed ID: 18336052
[TBL] [Abstract][Full Text] [Related]
8. Safety evaluation of desloratadine in allergic rhinitis.
González-Núñez V; Valero A; Mullol J
Expert Opin Drug Saf; 2013 May; 12(3):445-53. PubMed ID: 23574541
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
Ortonne JP; Grob JJ; Auquier P; Dreyfus I
Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
[TBL] [Abstract][Full Text] [Related]
10. Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders.
DuBuske LM
Expert Opin Pharmacother; 2005 Nov; 6(14):2511-23. PubMed ID: 16259582
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
Augustin M; Ehrle S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):292-9. PubMed ID: 19438819
[TBL] [Abstract][Full Text] [Related]
12. Desloratadine: an update of its efficacy in the management of allergic disorders.
Murdoch D; Goa KL; Keam SJ
Drugs; 2003; 63(19):2051-77. PubMed ID: 12962522
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years.
Salmun LM; Herron JM; Banfield C; Padhi D; Lorber R; Affrime MB
Clin Ther; 2000 May; 22(5):613-21. PubMed ID: 10868558
[TBL] [Abstract][Full Text] [Related]
14. Evidence of desloratadine syrup efficacy and tolerability in children with pollen-induced allergic rhinitis.
Rossi GA; Tosca MA; Passalacqua G; Bianchi B; Le Grazie C; Canonica GW
Allergy; 2005 Mar; 60(3):416-7. PubMed ID: 15679739
[No Abstract] [Full Text] [Related]
15. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
[TBL] [Abstract][Full Text] [Related]
17. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review.
Bachert C; van Cauwenberge P
Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184
[TBL] [Abstract][Full Text] [Related]
18. Desloratadine.
McClellan K; Jarvis B
Drugs; 2001; 61(6):789-96; discussion 797. PubMed ID: 11398910
[TBL] [Abstract][Full Text] [Related]
19. [Multicenter study of the effectiveness and tolerability of desloratadine in seasonal allergic rhinitis].
Farkas H
Orv Hetil; 2003 May; 144(21):1021-4. PubMed ID: 12847854
[TBL] [Abstract][Full Text] [Related]
20. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
Glass DJ; Harper AS
BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
